 NEW YORK--BUSINESS WIRE--Lazard Ltd NYSE: LAZ today released its fourth annual in-depth study of strategic challenges and opportunities in the global healthcare industry, surveying 200 C-level executives and investors across three global sectors: Biopharmaceuticals; Medical Devices and Diagnostics; and Healthcare Services. As the COVID-19 pandemic continues to evolve, this years study focuses on the healthcare leaders pandemic-related challenges and expectations, as well as the strategic 